4//SEC Filing
SALIX PHARMACEUTICALS LTD 4
Accession 0001209191-05-031640
CIK 0001009356operating
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:33 PM ET
Size
7.3 KB
Accession
0001209191-05-031640
Insider Transaction Report
Form 4
Taylor David N MD
VP - Chief Medical Officer
Transactions
- Award
Option to Buy Common Stock
2005-06-09+10,500→ 10,500 totalExercise: $17.63Exp: 2015-06-09→ Common Stock (10,500 underlying)
Holdings
- 100,000
Option to Buy Common Stock
Exercise: $22.76Exp: 2014-09-01→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]Option vests at a rate of 1/48th per month, with a vesting commencement date of July 1, 2005.
- [F2]Option vests monthly over 48 months, with a 1/4 of the shares vesting on September 1, 2005 and the remainder vesting at a rate of 1/48th per month thereafter.
Documents
Issuer
SALIX PHARMACEUTICALS LTD
CIK 0001009356
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001009356
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 4:33 PM ET
- Size
- 7.3 KB